Nuwellis (NUWE) Competitors $1.22 -0.08 (-6.15%) (As of 02:35 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends NUWE vs. PXDT, NURO, INBS, PSTV, BTCY, CUTR, STSS, AEMD, CTCX, and CHEKShould you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include Pixie Dust Technologies (PXDT), NeuroMetrix (NURO), Intelligent Bio Solutions (INBS), Plus Therapeutics (PSTV), Biotricity (BTCY), Cutera (CUTR), Sharps Technology (STSS), Aethlon Medical (AEMD), Carmell (CTCX), and Check-Cap (CHEK). These companies are all part of the "medical equipment" industry. Nuwellis vs. Pixie Dust Technologies NeuroMetrix Intelligent Bio Solutions Plus Therapeutics Biotricity Cutera Sharps Technology Aethlon Medical Carmell Check-Cap Pixie Dust Technologies (NASDAQ:PXDT) and Nuwellis (NASDAQ:NUWE) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, community ranking, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends. Which has better earnings & valuation, PXDT or NUWE? Pixie Dust Technologies has higher earnings, but lower revenue than Nuwellis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPixie Dust Technologies$6.30M1.37-$12.53MN/AN/ANuwellis$8.86M0.26-$20.21M-$116.41-0.01 Is PXDT or NUWE more profitable? Pixie Dust Technologies has a net margin of 0.00% compared to Nuwellis' net margin of -169.54%. Pixie Dust Technologies' return on equity of 0.00% beat Nuwellis' return on equity.Company Net Margins Return on Equity Return on Assets Pixie Dust TechnologiesN/A N/A N/A Nuwellis -169.54%-28,159.25%-207.24% Which has more risk & volatility, PXDT or NUWE? Pixie Dust Technologies has a beta of -0.25, suggesting that its share price is 125% less volatile than the S&P 500. Comparatively, Nuwellis has a beta of 0.36, suggesting that its share price is 64% less volatile than the S&P 500. Does the MarketBeat Community favor PXDT or NUWE? Nuwellis received 21 more outperform votes than Pixie Dust Technologies when rated by MarketBeat users. However, 100.00% of users gave Pixie Dust Technologies an outperform vote while only 53.66% of users gave Nuwellis an outperform vote. CompanyUnderperformOutperformPixie Dust TechnologiesOutperform Votes1100.00% Underperform VotesNo VotesNuwellisOutperform Votes2253.66% Underperform Votes1946.34% Does the media prefer PXDT or NUWE? In the previous week, Nuwellis had 1 more articles in the media than Pixie Dust Technologies. MarketBeat recorded 1 mentions for Nuwellis and 0 mentions for Pixie Dust Technologies. Nuwellis' average media sentiment score of 0.67 beat Pixie Dust Technologies' score of 0.00 indicating that Nuwellis is being referred to more favorably in the news media. Company Overall Sentiment Pixie Dust Technologies Neutral Nuwellis Positive Do analysts rate PXDT or NUWE? Pixie Dust Technologies currently has a consensus target price of $5.21, indicating a potential upside of 798.28%. Nuwellis has a consensus target price of $17.00, indicating a potential upside of 1,293.44%. Given Nuwellis' stronger consensus rating and higher possible upside, analysts plainly believe Nuwellis is more favorable than Pixie Dust Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pixie Dust Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Nuwellis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Do insiders & institutionals have more ownership in PXDT or NUWE? 0.4% of Pixie Dust Technologies shares are held by institutional investors. Comparatively, 3.1% of Nuwellis shares are held by institutional investors. 2.6% of Nuwellis shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryNuwellis beats Pixie Dust Technologies on 10 of the 16 factors compared between the two stocks. Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Get Nuwellis News Delivered to You Automatically Sign up to receive the latest news and ratings for NUWE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUWE vs. The Competition Export to ExcelMetricNuwellisElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.43M$3.37B$5.04B$8.81BDividend YieldN/A1.65%5.16%4.07%P/E Ratio-0.0119.01130.5317.82Price / Sales0.2788.041,183.8674.55Price / CashN/A46.1733.6132.53Price / Book0.073.734.684.68Net Income-$20.21M$92.21M$119.23M$226.08M7 Day Performance-26.97%-3.40%-1.83%-1.04%1 Month Performance-33.33%6.80%-3.61%1.04%1 Year Performance-93.89%17.06%31.74%26.28% Nuwellis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NUWENuwellis2.9067 of 5 stars$1.22-6.2%$17.00+1,293.4%-93.8%$2.28M$8.86M-0.0159PXDTPixie Dust Technologies1.9826 of 5 stars$0.58flat$5.21+798.3%N/A$8.63M$6.30M0.0078Upcoming EarningsNURONeuroMetrix0.5217 of 5 stars$4.16-4.1%N/A+11.5%$8.49M$5.90M0.0020Analyst ForecastNews CoverageGap DownINBSIntelligent Bio Solutions0.331 of 5 stars$1.63+16.1%N/A-61.1%$7.13M$3.11M0.0010News CoverageGap UpPSTVPlus Therapeutics3.2264 of 5 stars$1.20+0.8%$14.00+1,066.7%-37.4%$7.08M$4.91M0.0020Analyst RevisionGap UpBTCYBiotricityN/A$0.28-11.1%N/A-66.9%$6.33M$12.06M-0.2340Analyst ForecastAnalyst RevisionNews CoverageCUTRCutera1.11 of 5 stars$0.31+1.3%$3.00+880.1%-86.7%$6.18M$212.37M-0.05430Analyst ForecastGap DownSTSSSharps Technology0.7782 of 5 stars$3.42+5.9%N/AN/A$6.16MN/A-0.383Gap DownAEMDAethlon Medical2.8661 of 5 stars$0.39-1.2%$7.00+1,717.2%-77.2%$5.38M$570,000.00-0.1410CTCXCarmellN/A$0.25+1.3%N/A-90.9%$5.21MN/A0.0014CHEKCheck-Cap0.5192 of 5 stars$0.80+5.0%N/A-76.9%$4.68MN/A-0.2780Upcoming EarningsNews CoverageGap Up Related Companies and Tools Related Companies PXDT Alternatives NURO Alternatives INBS Alternatives PSTV Alternatives BTCY Alternatives CUTR Alternatives STSS Alternatives AEMD Alternatives CTCX Alternatives CHEK Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NUWE) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuwellis, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuwellis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
